Crestchem Intrinsic Value
Crestchem (CRSTCHM) median intrinsic value is ₹106.67 from 9 valuation models (range ₹33–₹213), vs current price ₹130.70 — -18.4% downside (Trading Above Median Value), margin of safety -22.5%. Also explore CRSTCHM price trends to track price trends across different timeframes.
CRSTCHM Valuation Methods Summary — DCF, Graham Number & P/E
Crestchem intrinsic value across 9 models vs current price ₹130.70 — upside/downside and value range per method. For current market price and key ratios, visit Crestchem share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹176.16 | ₹140.93 - ₹211.39 | +34.8% | EPS: ₹14.68, Sector P/E: 12x |
| Book Value Method | asset | ₹33.33 | ₹30.00 - ₹36.66 | -74.5% | Book Value/Share: ₹33.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹106.67 | ₹96.00 - ₹117.34 | -18.4% | Revenue/Share: ₹133.33, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹160.00 | ₹144.00 - ₹176.00 | +22.4% | EBITDA: ₹8.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹90.56 | ₹72.45 - ₹108.67 | -30.7% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹93.95 | ₹84.56 - ₹103.35 | -28.1% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹120.96 | ₹108.86 - ₹133.06 | -7.5% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹213.33 | ₹192.00 - ₹234.66 | +63.2% | ROE: 40.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹66.67 | ₹60.00 - ₹73.34 | -49.0% | EPS: ₹14.68, BVPS: ₹33.33 |
CRSTCHM Intrinsic Value vs Market Price — All Valuation Models
Crestchem fair value range ₹33–₹213 vs current market price ₹130.70 across 9 valuation models. Browse Crestchem financial data for revenue, profit, balance sheet and cash flow data.
CRSTCHM Intrinsic Value Analysis — Undervalued or Overvalued?
Crestchem median intrinsic value ₹106.67, current price ₹130.70 — Trading Above Median Value by 18.4%, margin of safety -22.5%.
What is the intrinsic value of CRSTCHM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Crestchem (CRSTCHM) is ₹106.67 (median value). With the current market price of ₹130.70, this represents a -18.4% variance from our estimated fair value.
The valuation range spans from ₹33.33 to ₹213.33, indicating ₹33.33 - ₹213.33.
Is CRSTCHM undervalued or overvalued?
Based on our multi-method analysis, Crestchem (CRSTCHM) appears to be trading above median value by approximately 18.4%.
CRSTCHM Financial Health — Key Ratios vs Industry Benchmarks
Crestchem financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 40.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.50x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
CRSTCHM Cash Flow Quality — Operating & Free Cash Flow
Crestchem operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |